Management of Threatened Abortion or Spontaneous Miscarriage
For patients with threatened abortion or spontaneous miscarriage, immediate assessment of hemodynamic stability, followed by appropriate management based on clinical presentation is recommended, with consideration for anti-D immunoglobulin administration in Rh-negative women.
Initial Assessment
Clinical Evaluation
- Assess for:
- Amount and pattern of vaginal bleeding
- Presence of abdominal pain or cramping
- Vital signs (blood pressure, heart rate) to determine hemodynamic stability
- Cervical status (open vs. closed)
- Presence of tissue passage
Diagnostic Testing
- Perform transvaginal ultrasound to:
- Confirm intrauterine pregnancy
- Assess fetal viability (cardiac activity)
- Rule out ectopic pregnancy
- Evaluate for retained products of conception
- Obtain quantitative β-hCG level
- Check blood type and Rh status
- Consider complete blood count if significant bleeding
Management Algorithm
For Threatened Abortion (Bleeding with Closed Cervix and Viable Pregnancy)
Provide reassurance and counseling about prognosis
Consider progesterone supplementation
Recommend pelvic rest and limited activity until bleeding resolves
- Avoid sexual intercourse
- Avoid strenuous physical activity
Schedule follow-up within 1-2 weeks for repeat ultrasound
For Incomplete/Inevitable Abortion (Open Cervix or Non-Viable Pregnancy)
Discuss management options:
- Expectant management: allowing natural completion of the miscarriage
- Medical management: using medications to complete the process
- Surgical management: uterine evacuation (vacuum aspiration or D&C)
For expectant management:
- Appropriate for hemodynamically stable patients
- Counsel about expected bleeding and cramping
- Provide pain management options
- Arrange follow-up within 1-2 weeks to confirm complete expulsion
For medical management:
- Offer misoprostol (typically 800 mcg vaginally)
- Provide pain management
- Arrange follow-up within 1-2 weeks to confirm complete expulsion
For surgical management:
- Indicated for:
- Heavy bleeding with hemodynamic instability
- Patient preference
- Failed expectant or medical management
- Evidence of infection
- Indicated for:
Rh Immunoglobulin Administration
- Administer anti-D immunoglobulin (RhIg) to all Rh-negative, unsensitized women with threatened abortion or spontaneous miscarriage 4
- Recommended dose: 50 μg within 72 hours of bleeding onset 4
- If 50 μg dose unavailable, a 300 μg dose is acceptable 4
- This is critical to prevent Rh alloimmunization which could affect future pregnancies 4
Emotional Support and Follow-up
- Provide emotional support and acknowledge the psychological impact of pregnancy loss 5
- Express empathy, listen actively, and normalize the experience to mitigate guilt and self-blame 5
- Consider referral to pregnancy loss support organizations if needed
- Schedule follow-up appointment to:
- Confirm complete expulsion of pregnancy tissue
- Address emotional concerns
- Discuss contraception if desired
- Provide preconception counseling when appropriate
Special Considerations
For patients with recurrent miscarriages, consider evaluation for:
- Uterine anatomical abnormalities
- Endocrine disorders (thyroid dysfunction, diabetes)
- Antiphospholipid syndrome
- Genetic factors
If IUD is present with confirmed pregnancy:
Pitfalls and Caveats
- Do not assume ectopic pregnancy is ruled out based on low β-hCG levels alone; ectopic pregnancies can present at any β-hCG level 4
- Avoid delaying ultrasound when β-hCG is below discriminatory threshold as ectopic pregnancy rupture can occur at very low β-hCG levels 4
- Do not withhold RhIg in Rh-negative women with threatened abortion, as fetomaternal hemorrhage can occur even with minimal bleeding 4
- Recognize that threatened abortion may have significant psychological impact requiring appropriate emotional support 5